Facebook
Twitter
Telegram
Fehler meldenCyclacel Pharmaceuticals Finanzdaten 2011-2024 | CYCC
Jahresabschluß Cyclacel Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
2.31 M | 459 K | 29 M | 34.7 M | 11.4 M | 9.55 M | 13.1 M | 16.3 M | 11.7 M | 12.7 M | 55 M | 41 M | 28.7 M |
Anteile |
1.06 M | 628 K | 8.93 M | 4.93 M | 816 K | 605 K | 382 K | 171 K | 136 K | 91.5 K | 63.2 K | 29.9 K | 29.9 K |
Kurshistorie |
2.18 | 0.73 | 3.25 | 6.9 | 10.6 | 16 | 30.6 | 67.8 | 84 | 360 | 931 | 1.33 K | 1.21 K |
Nettogewinn |
-22.6 M | -21.2 M | -18.9 M | -8.44 M | -7.83 M | -7.29 M | -7.47 M | -11.8 M | -14.3 M | -19.4 M | -10.2 M | -13.2 M | -15.2 M |
Umsatz |
420 K | - | - | 5.88 K | - | 150 K | - | 843 K | 1.94 M | 1.73 M | 1.08 M | 69 K | 699 K |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | 5.88 K | - | - | - | - | 1.94 M | 1.73 M | 1.08 M | 69 K | 339 K |
Betriebsergebnis |
-25.5 M | -27.7 M | -22.9 M | -10.6 M | -9.68 M | -9.55 M | -9.49 M | -14.2 M | -16.2 M | -22.4 M | -18 M | -15.1 M | -15.7 M |
Zinsaufwendungen |
50 K | 1.3 M | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-25.4 M | -27.6 M | -22.9 M | -10.6 M | -9.66 M | -9.52 M | -9.46 M | -14 M | -16 M | -22.3 M | -17.9 M | -15 M | -16.1 M |
Betriebsaufwand |
25.9 M | 27.7 M | - | 10.6 M | 9.68 M | 9.7 M | 9.49 M | 15 M | 18.1 M | 24.2 M | 19.1 M | 15.2 M | 16.7 M |
Allgemeine und Verwaltungsausgaben |
6.72 M | 7.38 M | 7.46 M | 5.88 M | 5.02 M | 5.37 M | 5.25 M | 5.52 M | 5.73 M | 5.89 M | 7.78 M | 8.58 M | 7.52 M |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich Cyclacel Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
12.6 M | 12.5 M | 12.5 M | 12.3 M | 10.1 M | 9.99 M | 9.99 M | 9.37 M | 9.23 M | 7.01 M | 6.25 M | 4.86 M | 3.85 M | 860 K | 860 K | 860 K | 860 K | 682 K | 12.5 M | 12 M | 12 M | 12 M | 12 M | 9.84 M | 4.43 M | 4.27 M | 4.26 M | 3.47 M | 3 M | 2.97 M | 2.97 M | 2.89 M | 2.87 M | 26.1 M | 23.2 M | 22.7 M | 22.6 M | 19.5 M | 19.4 M | 17.8 M | 13.9 M | 9.79 M | 8.69 M | 8.43 M | 8.43 M | 7.82 M | 7.75 M | 7.67 M | 46.6 M | 46.6 M |
Nettogewinn |
-5.45 M | -5.8 M | - | -5.1 M | -4.58 M | -4.11 M | - | -4.99 M | -5.13 M | -3.48 M | - | -2.26 M | -2.17 M | -1.22 M | - | -1.9 M | -1.78 M | -1.84 M | - | -2.07 M | -1.85 M | -1.35 M | - | -1.86 M | -2.19 M | -1.56 M | - | -2.95 M | -2.96 M | -3.04 M | - | -2.71 M | -3.35 M | -4.91 M | - | -4.91 M | -4.81 M | -4.87 M | - | -5 M | 1.49 M | -3.08 M | - | -1.89 M | -3.58 M | -2.96 M | - | -3.44 M | -3.55 M | -4.59 M |
Umsatz |
373 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 205 K | - | 139 K | - | 715 K | 296 K | 512 K | - | 735 K | 356 K | 396 K | - | 309 K | 264 K | 212 K | - | 38 K | 26 K | 161 K | - | 164 K | 168 K | 192 K |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-5.93 M | -7.32 M | - | -6.47 M | -5.78 M | -6.56 M | - | -6 M | -6.1 M | -4.3 M | - | -2.57 M | -2.47 M | -2.42 M | - | -2.35 M | -2.34 M | -2.2 M | - | -2.46 M | -2.46 M | -2.16 M | - | -2.11 M | -2.49 M | -2.69 M | - | -3.48 M | -3.76 M | -3.74 M | - | -3.39 M | -3.62 M | -5.3 M | - | -5.67 M | -5.58 M | -5.41 M | - | -5.8 M | -4.15 M | -4.05 M | - | -3.52 M | -3.81 M | -3.12 M | - | -3.88 M | -3.8 M | -4.8 M |
Zinsaufwendungen |
-106 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -7.31 M | - | -6.44 M | -5.77 M | -6.55 M | - | -5.96 M | -6.07 M | -4.3 M | - | -2.56 M | -2.46 M | -2.42 M | - | -2.33 M | -2.33 M | -2.2 M | - | -2.43 M | -2.45 M | -2.16 M | - | -2.09 M | -2.47 M | -2.68 M | - | -3.37 M | -3.68 M | -3.7 M | - | -3.24 M | -3.52 M | -5.25 M | - | -5.56 M | -5.53 M | -5.39 M | - | -5.74 M | -4.12 M | -4.02 M | - | -3.48 M | -3.78 M | -3.1 M | - | -3.63 M | -3.62 M | -4.71 M |
Betriebsaufwand |
6.3 M | 7.32 M | - | 6.47 M | 5.78 M | 6.56 M | - | 6 M | 6.1 M | 4.3 M | - | - | - | - | - | - | 2.34 M | 2.2 M | - | 2.46 M | 2.46 M | 2.16 M | - | 2.11 M | 2.49 M | 2.69 M | - | 3.68 M | 3.98 M | 3.88 M | - | 4.11 M | 3.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
1.58 M | 1.64 M | - | 2.05 M | 1.58 M | 1.6 M | - | 1.78 M | 2 M | 1.74 M | - | 1.5 M | 1.31 M | 1.32 M | - | 1.28 M | 1.18 M | 1.19 M | - | 1.25 M | 1.28 M | 1.36 M | - | 1.15 M | 1.27 M | 1.38 M | - | 1.27 M | 1.34 M | 1.38 M | - | 1.2 M | 1.33 M | 1.47 M | - | 1.43 M | 1.39 M | 1.46 M | - | 1.53 M | 1.79 M | 2.68 M | - | 2.03 M | 2.12 M | 1.77 M | - | 1.81 M | 2.03 M | 1.81 M |
Alle Zahlen in USD-Währung